STAT+: Pharmalittle: FTC suit over Amgen spotlights ‘bundling’ deals with insurers; FDA staff says Pfizer RSV vaccine is effective
STAT
MAY 17, 2023
Simply put, this occurs when a drug company combines two or more medicines in a package deal for health plans and pharmacy benefit managers, which determine lists of medicines that are covered by insurance. The FDA is slated to make a decision on whether to clear the shot in August. Continue to STAT+ to read the full story…
Let's personalize your content